Wanjiru Waruiru1, Andrea A Kim, Davies O Kimanga, James Ng'ang'a, Sandra Schwarcz, Lucy Kimondo, Anne Ng'ang'a, Mamo Umuro, Mary Mwangi, James K Ojwang', William K Maina. 1. *Global Health Sciences, University of California, San Francisco, San Francisco, CA; †Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; ‡National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; §Kenya National Bureau of Statistics, Ministry of Planning, Nairobi, Kenya; ‖National Council for Population and Development, Ministry of Planning and National Development, Nairobi, Kenya; and ¶National Public Health Laboratory Services, Ministry of Health, Nairobi, Kenya.
Abstract
BACKGROUND: Cross-sectional population-based surveys are essential surveillance tools for tracking changes in HIV epidemics. In 2007, Kenya implemented the first AIDS Indicator Survey [Kenya AIDS Indicator Survey (KAIS) 2007)], a nationally representative, population-based survey that collected demographic and behavioral data and blood specimens from individuals aged 15-64 years. Kenya's second AIDS Indicator Survey (KAIS 2012) was conducted to monitor changes in the epidemic, evaluate HIV prevention, care, and treatment initiatives, and plan for an efficient and effective response to the HIV epidemic. METHODS: KAIS 2012 was a cross-sectional 2-stage cluster sampling design, household-based HIV serologic survey that collected information on households as well as demographic and behavioral data from Kenyans aged 18 months to 64 years. Participants also provided blood samples for HIV serology and other related tests at the National HIV Reference Laboratory. RESULTS: Among 9300 households sampled, 9189 (98.8%) were eligible for the survey. Of the eligible households, 8035 (87.4%) completed household-level questionnaires. Of 16,383 eligible individuals aged 15-64 years and emancipated minors aged less than 15 years in these households, 13,720 (83.7%) completed interviews; 11,626 (84.7%) of the interviewees provided a blood specimen. Of 6302 eligible children aged 18 months to 14 years, 4340 (68.9%) provided a blood specimen. Of the 2094 eligible children aged 10-14 years, 1661 (79.3%) completed interviews. CONCLUSIONS: KAIS 2012 provided representative data to inform a strategic response to the HIV epidemic in the country.
BACKGROUND: Cross-sectional population-based surveys are essential surveillance tools for tracking changes in HIV epidemics. In 2007, Kenya implemented the first AIDS Indicator Survey [Kenya AIDS Indicator Survey (KAIS) 2007)], a nationally representative, population-based survey that collected demographic and behavioral data and blood specimens from individuals aged 15-64 years. Kenya's second AIDS Indicator Survey (KAIS 2012) was conducted to monitor changes in the epidemic, evaluate HIV prevention, care, and treatment initiatives, and plan for an efficient and effective response to the HIV epidemic. METHODS: KAIS 2012 was a cross-sectional 2-stage cluster sampling design, household-based HIV serologic survey that collected information on households as well as demographic and behavioral data from Kenyans aged 18 months to 64 years. Participants also provided blood samples for HIV serology and other related tests at the National HIV Reference Laboratory. RESULTS: Among 9300 households sampled, 9189 (98.8%) were eligible for the survey. Of the eligible households, 8035 (87.4%) completed household-level questionnaires. Of 16,383 eligible individuals aged 15-64 years and emancipated minors aged less than 15 years in these households, 13,720 (83.7%) completed interviews; 11,626 (84.7%) of the interviewees provided a blood specimen. Of 6302 eligible children aged 18 months to 14 years, 4340 (68.9%) provided a blood specimen. Of the 2094 eligible children aged 10-14 years, 1661 (79.3%) completed interviews. CONCLUSIONS: KAIS 2012 provided representative data to inform a strategic response to the HIV epidemic in the country.
Authors: Mary Mwangi; Rebecca Bunnell; Raymond Nyoka; Anthony Gichangi; Ernest Makokha; Andrea Kim; George Kichamu; Lawrence Marum; Jared Ichwara; Jonathan Mermin Journal: J Acquir Immune Defic Syndr Date: 2011-09-01 Impact factor: 3.731
Authors: Miguel Arredondo; Carolina Garrido; Neil Parkin; Natalia Zahonero; Silvia Bertagnolio; Vincent Soriano; Carmen de Mendoza Journal: J Clin Microbiol Date: 2011-12-14 Impact factor: 5.948
Authors: Zebedee Mwandi; Rebecca Bunnell; Peter Cherutich; Jonathan Mermin; Andrea A Kim; Anthony Gichangi; Patrick Mureithi; Timothy A Kellogg; Tom Oluoch; James Muttunga; Carol Ngare; Evelyn Kim; Reinhard Kaiser Journal: Bull World Health Organ Date: 2012-06-19 Impact factor: 9.408
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: James K Ojwang'; Veronica C Lee; Anthony Waruru; Victor Ssempijja; John G Ng'ang'a; Brian E Wakhutu; Nicholas O Kandege; Danson K Koske; Samuel M Kamiru; Kenneth O Omondi; Mutua Kakinyi; Andrea A Kim; Tom Oluoch Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Reinhard Kaiser; Rebecca Bunnell; Allen Hightower; Andrea A Kim; Peter Cherutich; Mary Mwangi; Tom Oluoch; Sufia Dadabhai; Patrick Mureithi; Nelly Mugo; Jonathan Mermin Journal: PLoS One Date: 2011-03-15 Impact factor: 3.240
Authors: Sian Floyd; Anna Molesworth; Albert Dube; Amelia C Crampin; Rein Houben; Menard Chihana; Alison Price; Ndoliwe Kayuni; Jacqueline Saul; Neil French; Judith R Glynn Journal: AIDS Date: 2013-01-14 Impact factor: 4.177
Authors: Peter Cherutich; Reinhard Kaiser; Jennifer Galbraith; John Williamson; Ray W Shiraishi; Carol Ngare; Jonathan Mermin; Elizabeth Marum; Rebecca Bunnell Journal: PLoS One Date: 2012-05-04 Impact factor: 3.240
Authors: Anne Ng'ang'a; Wanjiru Waruiru; Carol Ngare; Victor Ssempijja; Thomas Gachuki; Inviolata Njoroge; Patricia Oluoch; Davies O Kimanga; William K Maina; Rex Mpazanje; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Marielle S Goyette; Peter M Mutiti; David Bukusi; Beatrice M Wamuti; Felix A Otieno; Peter Cherutich; Matthew R Golden; Hans Spiegel; Barbra A Richardson; Anne Ngʼangʼa; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731
Authors: Sumathi Sivapalasingam; R Scott McClelland; Jacques Ravel; Aabid Ahmed; Charles M Cleland; Pawel Gajer; Musa Mwamzaka; Fatma Marshed; Juma Shafi; Linnet Masese; Mark Fajans; Molly E Anderson; Walter Jaoko; Ann E Kurth Journal: AIDS Res Hum Retroviruses Date: 2014-09-29 Impact factor: 2.205
Authors: Marielle Goyette; Beatrice Muthoni Wamuti; Mercy Owuor; David Bukusi; Peter Mutiti Maingi; Felix Abuna Otieno; Peter Cherutich; Anne Ng'ang'a; Carey Farquhar Journal: AIDS Patient Care STDS Date: 2016-11 Impact factor: 5.078
Authors: Daniel Kimani; Rachel Kamau; Victor Ssempijja; Katherine Robinson; Tom Oluoch; Mercy Njeru; Jane Mwangi; David Njogu; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Evelyn W Ngugi; Andrea A Kim; Raymond Nyoka; Lucy Ng'ang'a; Irene Mukui; Bernadette Ng'eno; George W Rutherford Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Davies O Kimanga; Samuel Ogola; Mamo Umuro; Anne Ng'ang'a; Lucy Kimondo; Patrick Murithi; James Muttunga; Wanjiru Waruiru; Ibrahim Mohammed; Shahnaaz Sharrif; Kevin M De Cock; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Bernadette N Ng'eno; Timothy A Kellogg; Andrea A Kim; Anne Mwangi; Mary Mwangi; Joyce Wamicwe; George W Rutherford Journal: Int J STD AIDS Date: 2018-02-28 Impact factor: 1.359
Authors: Peter Sifuna; Mary Oyugi; Bernhards Ogutu; Ben Andagalu; Allan Otieno; Victorine Owira; Nekoye Otsyula; Janet Oyieko; Jessica Cowden; Lucas Otieno; Walter Otieno Journal: Int J Epidemiol Date: 2014-07-08 Impact factor: 7.196